MLchartDataset catalogue

yttrium Y 90-epratuzumab tetraxetan

Term · Oncology and biomedicine · MLC-T-ONC-009452

A substance being studied in the treatment of certain types of B-cell cancer. Epratuzumab is a monoclonal antibody that binds to a protein called CD22, which is found on the surface of B cells. It is linked to a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90-epratuzumab tetraxetan is a type of radioimmunoconjugate.

Table 1. Record
IdentifierMLC-T-ONC-009452
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009452",
  "term": "yttrium Y 90-epratuzumab tetraxetan",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of certain types of B-cell cancer. Epratuzumab is a monoclonal antibody that binds to a protein called CD22, which is found on the surface of B cells. It is linked to a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90-epratuzumab tetraxetan is a type of radioimmunoconjugate.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/yttrium-y-90-epratuzumab-tetraxetan/"
}

Record 17,584 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.